Business StandardCenter·
RPG Life Sciences scouts for larger API assets after ₹215 cr acquisitions
The drugmaker has more than ₹500 crore of capital available and is evaluating businesses that can add differentiated chemistry, regulatory access and export capabilities
Read at Business Standard →



